HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Previous close
₹921.25
Day range
₹892.55 - ₹949.45
Year range
₹800.00 - ₹1,997.40
Market cap
47.27B INR
Avg Volume
133.63K
P/E ratio
42.60
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.17B | -1.47% |
Operating expense | 747.93M | 3.12% |
Net income | 207.75M | -29.41% |
Net profit margin | 9.56 | -28.34% |
Earnings per share | — | — |
EBITDA | 257.00M | -35.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.44B | 384.25% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 12.24B | — |
Shares outstanding | 50.67M | — |
Price to book | 3.82 | — |
Return on assets | — | — |
Return on capital | 3.20% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 207.75M | -29.41% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Founded
1992
Website
Employees
871
